Abstract
A strategy of early rhythm control for patients with recently diagnosed atrial fibrillation reduces the risk of cardiovascular events compared with usual care, according to findings from the EAST-AFNET 4 trial.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
